Heggland S J, Signs S A, Stalvey J R
Department of Biological Sciences, Kent State University, Ohio 44242, USA.
J Androl. 1997 Nov-Dec;18(6):646-55.
We previously reported a strain-related difference in basal 3beta-hydroxysteroid dehydrogenase-isomerase (3betaHSD) activity in response to testosterone in cultured Leydig cells. The data suggested that the response to testosterone was androgen receptor mediated and that testosterone was acting via a trans-acting factor distal to the androgen receptor to regulate Leydig cell basal 3betaHSD activity. This study was designed to determine whether the previous reported strain-related difference in basal 3betaHSD activity in response to testosterone was due to a difference at the 3betaHSD protein and/or at the mRNA level. In C57BL/6J Leydig cells, 2.0 microM testosterone significantly decreased basal 3betaHSD immunoreactive mass by day 6 in culture. Treatment with 2.0 microM testosterone and 2.0 microM hydroxyflutamide, an androgen receptor antagonist, negated the inhibitory effect of testosterone on C57BL/6J 3betaHSD immunoreactive mass. Treatment with 2.0 microM testosterone also significantly decreased 3betaHSD mRNA content in C57BL/6J Leydig cells, which was detectable on day 3 in culture. In contrast to Leydig cells from C57BL/6J mice, Leydig cells from C3H/HeJ mice were not susceptible to the inhibitory effect of testosterone on 3betaHSD. Treatment with 2.0 microM testosterone had no detectable effect on C3H/HeJ 3betaHSD immunoreactive mass or mRNA content at any time point in culture. These data indicate that the testosterone-induced loss of basal 3betaHSD activity in C57BL/6J Leydig cells can be accounted for by the loss of 3betaHSD immunoreactive mass, which is preceded by the loss of 3betaHSD mRNA, and that the strain-related difference in the regulation of 3betaHSD is present at all three levels. Thus, the putative trans-acting factor involved in the mechanism whereby testosterone decreases basal 3betaHSD is likely to regulate the amount of 3betaHSD mRNA.
我们之前报道过,在培养的睾丸间质细胞中,基础3β-羟基类固醇脱氢酶异构酶(3βHSD)活性对睾酮的反应存在品系相关差异。数据表明,对睾酮的反应是由雄激素受体介导的,并且睾酮是通过雄激素受体远端的反式作用因子来调节睾丸间质细胞基础3βHSD活性的。本研究旨在确定先前报道的基础3βHSD活性对睾酮反应的品系相关差异是否是由于3βHSD蛋白和/或mRNA水平的差异所致。在C57BL/6J睾丸间质细胞中,2.0微摩尔/升的睾酮在培养第6天时显著降低了基础3βHSD免疫反应性物质的含量。用2.0微摩尔/升的睾酮和2.0微摩尔/升的羟基氟他胺(一种雄激素受体拮抗剂)处理,可消除睾酮对C57BL/6J 3βHSD免疫反应性物质的抑制作用。用2.0微摩尔/升的睾酮处理也显著降低了C57BL/6J睾丸间质细胞中3βHSD mRNA的含量,在培养第3天时即可检测到。与C57BL/6J小鼠的睾丸间质细胞不同,C3H/HeJ小鼠的睾丸间质细胞对睾酮对3βHSD的抑制作用不敏感。在培养的任何时间点,用2.0微摩尔/升的睾酮处理对C3H/HeJ 3βHSD免疫反应性物质或mRNA含量均无明显影响。这些数据表明,C57BL/6J睾丸间质细胞中睾酮诱导的基础3βHSD活性丧失可归因于3βHSD免疫反应性物质的丧失,而这之前是3βHSD mRNA的丧失,并且3βHSD调节的品系相关差异在所有三个水平上都存在。因此,参与睾酮降低基础3βHSD机制的假定反式作用因子可能调节3βHSD mRNA的量。